Exercise behavior of ultramarathon runners: baseline findings from the ULTRA study

COVID-19 Infection in Ultramarathon Runners: Findings of the Ultrarunners Longitudinal TRAcking Study

OBJECTIVE

Ultramarathon runners are a unique patient population who have been shown to have a lower rate of severe chronic medical conditions. This study aimed to determine the effect that COVID-19 infection has had on this population and their running behavior.

DESIGN

The Ultrarunners Longitudinal TRAcking (ULTRA) Study is a large longitudinal study of ultramarathon runners. Questions on health status, running behavior, and COVID-19 infection were included in the most recent survey.

SETTING

Community survey.

PARTICIPANTS

Seven hundred thirty-four ultramarathon runners participated in the study.

INTERVENTIONS

None.

MAIN OUTCOME MEASURES

Personal, exercise, and COVID-19 infection history.

RESULTS

52.7% of study participants reported having been symptomatic from a COVID-19 infection, with 6.7% testing positive multiple times. Participants required a total of 4 days of hospitalization. The most common symptoms included fever (73.6%), fatigue (68.5%), sore throat (68.2%), runny nose (67.7%), and cough (67.4%). Cardiovascular symptoms, which are of particular interest in the running population, included shortness of breath (46.3%), tachycardia (44.7%), chest pain (36.2%), and wheezing (33.3%). A total of 50 subjects (6.8%) reported long COVID (symptoms lasting more than 12 weeks).

CONCLUSIONS

Severe COVID-19 infection has been rare in this population of ultramarathon runners, although symptomatic infection that affects running is common. To support the well-being of this group of highly active athletes, clinicians should appreciate that cardiovascular symptoms are common and the long-term significance of these symptoms in runners is unknown.

LEVEL OF EVIDENCE

Level 2 prospective study.

Arterial function in response to a 50 km ultramarathon in recreational athletes

This study was performed to determine whether prolonged endurance running results in acute endothelial dysfunction and wave-reflection, as endothelial dysfunction and arterial stiffness are cardiovascular risk factors. Vascular function (conduit artery/macrovascular and resistance artery/microvascular) was assessed in 11 experienced runners (8 males, 3 females) before, during and after a 50 km ultramarathon. Blood pressure (BP), heart rate (HR), wave reflection, augmentation index (AIx) and AIx corrected for HR (AIx75) were taken at all time points-Baseline (BL), following 10, 20, 30 and 40 km, 1 h post-completion (1HP) and 24 h post-completion (24HP). Flow-mediated dilatation (FMD) and inflammatory biomarkers were examined at BL, 1HP and 24HP. Reactive hyperaemia area under the curve (AUC) and shear rate AUC to peak dilatation were lower (∼75%) at 1HP compared with BL (P < 0.001 for both) and reactive hyperaemia was higher at 24HP (∼27%) compared with BL (P = 0.018). Compared to BL, both mean central systolic BP and mean central diastolic BP were 7% and 10% higher, respectively, following 10 km and 6% and 9% higher, respectively, following 20 km, and then decreased by 5% and 8%, respectively, at 24HP (P < 0.05 for all). AIx (%) decreased following 20 km and following 40 km compared with BL (P < 0.05 for both) but increased following 40 km when corrected for HR (AIx75) compared with BL (P = 0.02). Forward wave amplitude significantly increased at 10 km (15%) compared with BL (P = 0.049), whereas backward wave reflection and reflected magnitude were similar at all time points. FMD and baseline diameter remained similar. These data indicate preservation of macrovascular (endothelial) function, but not microvascular function resulting from the 50 km ultramarathon.

The Foot and Ankle in Ultramarathon Runners: Results of the Ultrarunners Longitudinal TRAcking (ULTRA) Study

Background

The foot and ankle play a critical role in ultramarathon running. Because foot and ankle injuries are the most common location of injury in this group, proper care is essential for prevention. In this sport, small issues can become big problems over such long distances, and understanding the preventative measures taken by ultramarathon runners may provide insight for other athletes looking to avoid similar problems. The purpose of this study was to examine the routine and preventative care of the foot and ankle, as well as injury rates, in this group of high-risk athletes.

Methods

The Ultrarunners Longitudinal TRAcking (ULTRA) Study is the largest known prospective longitudinal study of ultramarathon runners. In this portion of the study, participants reported general health status, running behavior and performance, as well as foot and ankle care, injuries, stretching frequency, and shoewear.

Results

A total of 734 ultramarathon runners participated in the study. This group ran a median of 40.2 km per week. Overall, 71.2% of active ultramarathon runners reported a foot or ankle injury in the previous 12 months. The most common injuries reported were plantar fasciitis (36.3%), Achilles tendinitis (24.0%), nonspecific foot pain (14.0%), and stress fractures (13.4%). Sit and reach flexibility test showed that 63.7% of runners could not reach past their toes. There were no significant correlations for sit and reach flexibility or stretching frequency with injury rate.

Conclusion

The high prevalence of foot and ankle injuries in ultramarathon runners does not appear to be influenced by arch type, foot strike pattern, orthotic usage, stretching behavior, or actual flexibility. A high percentage of the study runners used comfort as a shoe selection method, independent of alignment or foot strike pattern. These findings guide the clinician in shared decision making with runners about routine care, including injury prevention and shoe selection.

Level of Evidence

Level II, prospective study.

Muscle thickness and inflammation during a 50km ultramarathon in recreational runners

Purpose

This study examined changes in circulating levels of inflammatory cytokines [IL-6, sIL-6R, TNF-α, and calprotectin], skeletal muscle morphology, and muscle strength following a 50km race in non-elite athletes.

Methods

Eleven individuals (8 men; 3 women) underwent pre-race assessments of rectus femoris muscle thickness (resting and contracted) using ultrasound, isometric knee extensor torque, and plasma cytokines. Measures were repeated after 10km of running, the 50km finish (post-race), and again 24-hrs post-race.

Results

Compared with baseline values, Δ muscle thickness (resting to contracted) increased significantly 24 hrs post-race (11 ± 11% vs. 22 ± 8%; P = 0.01). Knee extensor torque was significantly reduced immediately post-race (151 ± 46 vs. 134 ± 43 Nm; P = 0.047) but remained similar to post-race values at 24 hrs post-race (P = 0.613). Compared with pre-race levels, IL-6 and calprotectin concentrations increased 302% and 50% after 10km, respectively (P<0.017 for both), peaked post-race (2598% vs. pre-race for IL-6 and 68% vs. pre-race for calprotectin; P = 0.018 for both), and returned to pre-race levels at 24-hrs post-race (P>0.05 for both). Creatine kinase levels rose steadily during and after the race, peaking 24-hrs post-race (184 ± 113 U/L pre-race vs. 1508 ± 1815 U/L 24-hrs post-race; P = 0.005).

Conclusion

This is the first report of delayed increases in Δ muscle thickness at 24 hrs post-50km, which are preceded by reductions in knee extensor torque and elevations in plasma IL-6, and calprotectin. Recreational athletes should consider the acute muscle inflammatory response when determining training and recovery strategies for 50km participation.

The Sex Difference in 6-h Ultra-Marathon Running—The Worldwide Trends from 1982 to 2020

Background and Objectives: The 6-h ultra-marathon is the shortest time-limited ultra-marathon race, but little has been investigated regarding this race format. Previously, only the age of peak performance in the context of longer time-limited ultra-marathons was determined. The purpose of this study was to investigate the trends in 6-h ultra-marathon races from 1982 to 2020 for female and male ultra-runners, the participation and performance by countries, the age of peak performance, and the differences in performance regarding countries. Materials and Methods: The sample included 23,203 female ultra-runners, aged 18–83 years, and 87,264 male ultra-runners, aged 18–85 years, who were finishers in a 6-h ultra-marathon held between 1982 and 2020. The age of peak performance was tested using the Kruskal–Wallis test, followed by the Bonferroni Correction. The difference in performance by countries was verified using a linear regression model with the fastest runners from Russia in women, and Tunisia in men, used as reference. Results: Over the years, the men-to-women ratio decreased. The mean age was 43.20 ± 9.30 years for female and 46.09 ± 10.17 years for male runners. Athletes in younger age groups were faster than athletes in older age groups. Most female and male participants originated from Germany. Women from Russia (10.01 ± 1.28 km/h) and men from Tunisia (12.16 ± 1.46 km/h) were the fastest. Conclusions: In summary, in 6-h ultra-marathons held between 1982 and 2020, the participation for both women and men increased, while the men-to-women ratio decreased. The mean age was higher in men compared to women. Most female and male runners originated from Germany, but the fastest women were from Russia, and the fastest men from Tunisia. Future studies need to investigate whether Russian women and Tunisian men are also the best in other distance-limited ultra-marathon races, such as 12-h and 24-h.

Potential Long-Term Health Problems Associated with Ultra-Endurance Running: A Narrative Review

It is well established that physical activity reduces all-cause mortality and can prolong life. Ultra-endurance running (UER) is an extreme sport that is becoming increasingly popular, and comprises running races above marathon distance, exceeding 6 h, and/or running fixed distances on multiple days. Serious acute adverse events are rare, but there is mounting evidence that UER may lead to long-term health problems. The purpose of this review is to present the current state of knowledge regarding the potential long-term health problems derived from UER, specifically potential maladaptation in key organ systems, including cardiovascular, respiratory, musculoskeletal, renal, immunological, gastrointestinal, neurological, and integumentary systems. Special consideration is given to youth, masters, and female athletes, all of whom may be more susceptible to certain long-term health issues. We present directions for future research into the pathophysiological mechanisms that underpin athlete susceptibility to long-term issues. Although all body systems can be affected by UER, one of the clearest effects of endurance exercise is on the cardiovascular system, including right ventricular dysfunction and potential increased risk of arrhythmias and hypertension. There is also evidence that rare cases of acute renal injury in UER could lead to progressive renal scarring and chronic kidney disease. There are limited data specific to female athletes, who may be at greater risk of certain UER-related health issues due to interactions between energy availability and sex-hormone concentrations. Indeed, failure to consider sex differences in the design of female-specific UER training programs may have a negative impact on athlete longevity. It is hoped that this review will inform risk stratification and stimulate further research about UER and the implications for long-term health.

Motivational Differences between 5K Runners, Marathoners and Ultramarathoners in Poland

The aim of the study was to determine the reasons for practicing different running distances (5K run, marathon, and ultramarathon), and to analyze the differences in each type according to gender, age, and marital status. An empirical study was conducted during the 2020 Karkonosze Winter Ultramarathon, 20th PKO Poznan Marathon, and 5K run—Parkrun Poznan and City Trail, over the course of which we interviewed 925 runners. A total of 267 ultramarathoners, 493 marathon runners, and 165 Parkrun and City Trail participants took part in the cross-sectional study, which used the diagnostic survey method. The questionnaire employed the division of motives used by the Motivation of Marathoners Scale (MOMS) by Masters et al., adapted to the Polish language by Dybała. No significant differences were found in any of the disciplines based on gender or marital status, although the results showed that weight concern increased with increasing age range in all the running distances analyzed. In addition, in 5K run and marathon runners, weight concern decreased in the 36 to 50 age range, but subsequently increased in those over 51 years of age. Therefore, it will be important for coaches and other professionals to consider athletes’ age when trying to understand their motives to participate in different disciplines.

Exercise Is Medicine? The Cardiorespiratory Implications of Ultra-marathon

Regular physical activity decreases the risk of cardiovascular disease, type II diabetes, obesity, certain cancers, and all-cause mortality. Nevertheless, there is mounting evidence that extreme exercise behaviors may be detrimental to human health. This review collates several decades of literature on the physiology and pathophysiology of ultra-marathon running, with emphasis on the cardiorespiratory implications. Herein, we discuss the prevalence and clinical significance of postrace decreases in lung function and diffusing capacity, respiratory muscle fatigue, pulmonary edema, biomarkers of cardiac injury, left/right ventricular dysfunction, and chronic myocardial remodeling. The aim of this article is to inform risk stratification for ultra-marathon and to edify best practice for personnel overseeing the events (i.e., race directors and medics).

Comprehensive assessment of cardiovascular structure and function and disease risk in middle-aged ultra-endurance athletes

BACKGROUND AND AIMS

Recent studies suggest that long-term endurance training may be damaging to the heart, thus increasing cardiovascular disease (CVD) risk. However, studies utilizing cardiac imaging are conflicting and lack measures of central and peripheral vascular structure and function, which are also independently predictive of CVD events.

METHODS

We performed a comprehensive assessment of cardiovascular structure and function in long-term (≥ 10 years) ultra-endurance athletes (ATH, 14 M/11 F, 50 ± 1 y) and physically active controls (CON, 9 M/9 F, 49 ± 2 y).

RESULTS

As expected, left ventricular mass and end-diastolic volume (echocardiography) were greater in ATH vs CON, whereas there was no difference in cardiac function at rest. Coronary artery calcium scores (computed tomography) were not statistically different between groups. There was no evidence of myocardial fibrosis (contrast magnetic resonance imaging) in any subject. Aortic stiffness (carotid-femoral pulse wave velocity) was lower in ATH vs CON (6.2 ± 0.2 vs 6.9 ± 0.2 m/s, p < 0.05), whereas carotid intima-media thickness (ultrasound) was not different between groups. Peripheral vascular endothelial function (flow-mediated vasodilation of the brachial artery) and microvascular function (peak blood velocity) in response to 5 min of forearm ischemia were not different between groups. Furthermore, there was no difference in 10-year coronary heart disease risk (ATH; 2.3 ± 0.5 vs CON; 1.6 ± 0.2%, p > 0.05).

CONCLUSIONS

Our data indicate that middle-aged ultra-endurance ATH do not have marked signs of widespread cardiovascular dysfunction or elevated CHD risk compared to CON meeting physical activity guidelines.

The Advantage of Supine and Standing Heart Rate Variability Analysis to Assess Training Status and Performance in a Walking Ultramarathon

Cardiac autonomic modulation of heart rate, assessed by heart rate variability (HRV), is commonly used to monitor training status. HRV is usually measured in athletes after awakening in the morning in the supine position. Whether recording during standing reveals additional information compared to supine remains unclear. We aimed to evaluate the association between short-duration HRV, assessed both in the supine and standing position, and a low-intensity long-duration performance (walking ultramarathon), as well as training experience. Twenty-five competitors in a 100 km walking ultramarathon underwent pre-race supine (12 min) and standing (6 min) HR recordings, whereas performance and subjective training experience were assessed post-race. There were no significant differences in both supine and standing HRV between finishers (n = 14) and non-finishers (n = 11, mean distance 67 km). In finishers, a slower race velocity was significantly correlated with a higher decrease in parasympathetic drive during position change [larger decrease in High Frequency power normalized units (HF_nu: r = −0.7, p = 0.01) and higher increase in the detrended fluctuation analysis alpha 1 index (DFA1: r = 0.6, p = 0.04)]. Highly trained athletes accounted for higher HF_nu during standing compared to poorly trained competitors (+11.5, p = 0.01). Similarly, greater training volume (total km/week) would predict higher HF_nu during standing (r = 0.5, p = 0.01). HRV assessment in both supine and standing position may provide additional information on the dynamic adaptability of cardiac autonomic modulation to physiologic challenges and therefore be more valuable for performance prediction than a simple assessment of supine HRV. Self-reported training experience may reliably associate with parasympathetic drive, therefore indirectly predicting long-term aerobic performance in ultramarathon walking races.

Participant Opinions and Expectations about Medical Services at Ultramarathons: Findings from the Ultrarunners Longitudinal TRAcking (ULTRA) Study

Background

This work explores the opinions and expectations of ultramarathon runners about medical services and their perceived quality during ultramarathons.

Methods

Focused questions related to medical services at ultramarathons were included in the 2018 survey of Ultrarunners Longitudinal TRAcking (ULTRA) Study enrollees.

Results

Among the 1,156 respondents, 83.2% agreed that ultramarathons should provide at least a minimum level of medical support with basic first aid and emergency transport services rated as the most important medical services, and individuals with basic first aid training rated as the most important medical providers at ultramarathons. Participant safety was felt to largely be the responsibility of each runner as well as the race and/or medical director. Among 832 respondents having completed an ultramarathon in 2016-2018, their impression of medical services at 4,853 ultramarathons was generally favorable. Of the four percent of times in which medical support was needed, it met expectations 74% of the time. Of the total of 240 different medical issues for which medical support was needed, blister management was the most common, accounting for 26.7% of issues.

Conclusions

Even though medical services receive minimal utilization during ultramarathons, ultramarathon runners largely believe that these events should provide at least a minimum level of medical support. Ultramarathon runners place a high onus for safety during ultramarathons on themselves, but they also place a high level of responsibility on race and medical directors, so it is prudent for the race and medical directors to consider this information and avoid a mismatch between runner expectations and the medical services actually provided.

Belief in the need for sodium supplementation during ultramarathons remains strong: findings from the Ultrarunners Longitudinal TRAcking (ULTRA) study

In the past, ultramarathon runners have commonly believed that consuming sodium supplements, as capsules or tablets, will prevent exercise-associated hyponatremia (EAH), dehydration, muscle cramping, and nausea, but accumulating evidence indicates that sodium supplementation during ultramarathons is not necessary and may be potentially dangerous. In this work, beliefs about whether sodium supplements should be made available at ultramarathons were assessed during 2018 among 1152 participants of the Ultrarunners Longitudinal TRAcking (ULTRA) study, of which 85.2% had completed an ultramarathon during 2014-2018. Two-thirds (66.4%) of study participants indicated that sodium supplements should be made available at ultramarathons, supported by beliefs that they prevent EAH (65.5%) and muscle cramping (59.1%). Of those indicating that sodium supplements should not be made available, 85.0% indicated it is because runners can provide their own, 27.9% indicated it is because they are not necessary, and 12.1% indicated they could increase thirst drive and cause overhydration. In general, there was a tendency for those who were older, less active in running ultramarathons in recent years, and with a longer history of ultramarathon running to be less likely to know that sodium supplements do not help prevent EAH, muscle cramping, and nausea. Novelty Ultramarathon runners continue to have misunderstandings about the need for sodium supplementation during ultramarathons. Few ultramarathon runners recognize that supplementing sodium intake beyond that in food and drink is generally not necessary during ultramarathons or that it could result in overhydration. Continued educational efforts are warranted to help ensure safe participation in the sport.

Physiology and Pathophysiology in Ultra-Marathon Running

In this overview, we summarize the findings of the literature with regards to physiology and pathophysiology of ultra-marathon running. The number of ultra-marathon races and the number of official finishers considerably increased in the last decades especially due to the increased number of female and age-group runners. A typical ultra-marathoner is male, married, well-educated, and ~45 years old. Female ultra-marathoners account for ~20% of the total number of finishers. Ultra-marathoners are older and have a larger weekly training volume, but run more slowly during training compared to marathoners. Previous experience (e.g., number of finishes in ultra-marathon races and personal best marathon time) is the most important predictor variable for a successful ultra-marathon performance followed by specific anthropometric (e.g., low body mass index, BMI, and low body fat) and training (e.g., high volume and running speed during training) characteristics. Women are slower than men, but the sex difference in performance decreased in recent years to ~10–20% depending upon the length of the ultra-marathon. The fastest ultra-marathon race times are generally achieved at the age of 35–45 years or older for both women and men, and the age of peak performance increases with increasing race distance or duration. An ultra-marathon leads to an energy deficit resulting in a reduction of both body fat and skeletal muscle mass. An ultra-marathon in combination with other risk factors, such as extreme weather conditions (either heat or cold) or the country where the race is held, can lead to exercise-associated hyponatremia. An ultra-marathon can also lead to changes in biomarkers indicating a pathological process in specific organs or organ systems such as skeletal muscles, heart, liver, kidney, immune and endocrine system. These changes are usually temporary, depending on intensity and duration of the performance, and usually normalize after the race. In longer ultra-marathons, ~50–60% of the participants experience musculoskeletal problems. The most common injuries in ultra-marathoners involve the lower limb, such as the ankle and the knee. An ultra-marathon can lead to an increase in creatine-kinase to values of 100,000–200,000 U/l depending upon the fitness level of the athlete and the length of the race. Furthermore, an ultra-marathon can lead to changes in the heart as shown by changes in cardiac biomarkers, electro- and echocardiography. Ultra-marathoners often suffer from digestive problems and gastrointestinal bleeding after an ultra-marathon is not uncommon. Liver enzymes can also considerably increase during an ultra-marathon. An ultra-marathon often leads to a temporary reduction in renal function. Ultra-marathoners often suffer from upper respiratory infections after an ultra-marathon. Considering the increased number of participants in ultra-marathons, the findings of the present review would have practical applications for a large number of sports scientists and sports medicine practitioners working in this field.

Sleep habits and strategies of ultramarathon runners

Among factors impacting performance during an ultramarathon, sleep is an underappreciated factor that has received little attention. The aims of this study were to characterize habitual sleep behaviors in ultramarathon runners and to examine strategies they use to manage sleep before and during ultramarathons. Responses from 636 participants to a questionnaire were considered. This population was found to sleep more on weekends and holidays (7–8 h to 8–9 h) than during weekdays (6–7 h to 7–8 h; p < 0.001). Work was a mediator of napping habits since 19–25% reported napping on work days and 37–56% on non-work days. There were 24.5% of the participants reporting sleep disorders, with more women (38.9%) reporting sleep problems than men (22.0%; p < 0.005). Mean (±SD) sleepiness score on the Epworth Sleepiness Scale was 8.9 ± 4.3 with 37.6% of respondents scoring higher than 10, reflecting excessive daytime sleepiness. Most of the study participants (73.9%) had a strategy to manage sleep preceding an ultramarathon, with 54.7% trying to increase their opportunities for sleep. Only 21% of participants reported that they had a strategy to manage sleep during ultramarathons, with micronaps being the most common strategy specified. Sub-analyses from 221 responses indicated that sleep duration during an ultramarathon was correlated with finish time for races lasting 36–60 h (r = 0.48; p < 0.01) or > 60 h (r = 0.44; p < 0.001). We conclude that sleep duration among ultramarathon runners was comparable to the general population and other athletic populations, yet they reported a lower prevalence of sleep disorders. Daytime sleepiness was among the lowest rates encountered in athletic populations, which may be related to the high percentage of nappers in our population. Sleep extension, by increasing sleep time at night and daytime napping, was the main sleep strategy to prepare for ultramarathons.

Untargeted Metabolomics Profiling of an 80.5 km Simulated Treadmill Ultramarathon

Metabolomic profiling of nine trained ultramarathon runners completing an 80.5 km self-paced treadmill-based time trial was carried out. Plasma samples were obtained from venous whole blood, collected at rest and on completion of the distance (post-80.5 km). The samples were analyzed by using high-resolution mass spectrometry in combination with both hydrophilic interaction (HILIC) and reversed phase (RP) chromatography. The extracted putatively identified features were modeled using Simca P 14.1 software (Umetrics, Umea, Sweden). A large number of amino acids decreased post-80.5 km and fatty acid metabolism was affected with an increase in the formation of medium-chain unsaturated and partially oxidized fatty acids and conjugates of fatty acids with carnitines. A possible explanation for the complex pattern of medium-chain and oxidized fatty acids formed is that the prolonged exercise provoked the proliferation of peroxisomes. The peroxisomes may provide a readily utilizable form of energy through formation of acetyl carnitine and other acyl carnitines for export to mitochondria in the muscles; and secondly may serve to regulate the levels of oxidized metabolites of long-chain fatty acids. This is the first study to provide evidence of the metabolic profile in response to prolonged ultramarathon running using an untargeted approach. The findings provide an insight to the effects of ultramarathon running on the metabolic specificities and alterations that may demonstrate cardio-protective effects.

Ultra-obligatory running among ultramarathon runners

Participants in the Ultrarunners Longitudinal TRAcking (ULTRA) Study were asked to answer "yes" or "no" to the question "If you were to learn, with absolute certainty, that ultramarathon running is bad for your health, would you stop your ultramarathon training and participation?" Among the 1349 runners, 74.1% answered "no". Compared with those answering "yes", they were younger (p < 0.0001), less likely to be married (p = 0.019), had less children (p = 0.0095), had a lower health orientation (p < 0.0001) though still high, and higher personal goal achievement (p = 0.0066), psychological coping (p < 0.0001) and life meaning (p = 0.0002) scores on the Motivations of Marathoners Scales. Despite a high health orientation, most ultramarathon runners would not stop running if they learned it was bad for their health as it appears to serve their psychological and personal achievement motivations and their task orientation such that they must perceive enhanced benefits that are worth retaining at the risk of their health.

[Not Available]

Zusammenfassung. In den vergangenen Jahrzehnten hat sich die Zahl der Ultraläufer vervielfacht, und viele Studien haben den Einfluss auf den Bewegungsapparat untersucht. Wir stellen die Erkenntnisse zu Schäden zusammen, die ein Ultramarathon an Gelenken und Muskeln verursachen kann. Die häufigsten Verletzungen bzw. Überlastungsschäden betreffen die untere Extremität, wobei Sprunggelenk und Knie am häufigsten betroffen sind. Bei sehr langen Läufen kommt es zu einer Anpassung mit Verdickung von Sehnen und Knorpel. Ein Ultramarathon kann zu einem ausgeprägten Muskelschaden führen, mit einem Anstieg von myozellulären Metaboliten wie Myoglobin, Laktat-Dehydrogenase und Creatinkinase.

Injuries and Health Considerations in Ultramarathon Runners

Ultramarathon runners are a relatively small and unique group of distance runners with somewhat different medical issues than other distance runners. This article outlines some of those differences so that clinicians caring for these runners in the clinic or at competitions might be better prepared.

Medical Coverage of Ultramarathons and Its Unique Challenges

Medical coverage of ultramarathons must take into account unique logistical, environmental, and psychological components in addition to the medical conditions that may arise. Each ultramarathon is unique and carries with it distinct specific challenges with regard to appropriate planning and organizing. The medical issues encountered with ultramarathons can overlap with those seen in other endurance events, but the extreme and protracted nature of ultramarathons also lends itself to various other medical challenges not frequently encountered in other aspects of sports medicine. This article gives an overview of logistical considerations that go into the medical planning, as well as information regarding diagnosis and acute management of some of the most common and most important conditions that one might encounter when covering an ultramarathon.

Pacing strategy in male elite and age group 100 km ultra-marathoners

Pacing strategy has been investigated in elite 100 km and elite 161 km (100 mile) ultra-marathoners, but not in age group ultra-marathoners. This study investigated changes in running speed over segments in male elite and age group 100 km ultra-marathoners with the assumption that running speed would decrease over segments with increasing age of the athlete. Running speed during segments in male elite and age group finishers for 5-year age groups (ie, 18-24 to 65-69 years) in the 100 km Lauf Biel in Switzerland was investigated during the 2000-2009 period. Average running speed over segment time station (TS) TS1-TS2 (56.1 km) was compared with running speed Start-TS1 (38 km) and Start-TS3 (76.7 km) and running speed TS2-TS3 was compared with running speed Start-Finish. For the top ten athletes in each edition, running speed decreased from 2000 to 2009 for TS1-TS2 and TS2-TS3 (P<0.0001) but not in TS3-Finish (P>0.05). During TS1-TS2, athletes were running at 98.0%±2.1% of the running speed of Start-TS1. In TS2-TS3, they were running at 94.6%±3.4% of the running speed of TS1-TS2. In TS3-Finish, they were running at 95.5%±3.8% of running speed in TS2-TS3. For age group athletes, running speed decreased in TS1-TS2 and TS2-TS3. In TS3-Finish, running speed remained unchanged with the exception of the age group 40-44 years for which running speed increased. Running speed showed the largest decrease in the age group 18-24 years. To summarize, the top ten athletes in each edition maintained their running speed in the last segment (TS3-Finish) although running speed decreased over the first two segments (TS1-TS2 and TS2-TS3). The best pacers were athletes in the age group 40-44 years, who were able to achieve negative pacing in the last segment (TS3-Finish) of the race. The negative pacing in the last segment (TS3-Finish) was likely due to environmental conditions, such as early dawn and the flat circuit in segment TS3-Finish of the race.

Do non-elite older runners slow down more than younger runners in a 100 km ultra-marathon?

Background

This study investigated changes in normalised running speed as a proxy for effort distribution over segments in male elite and age group 100 km ultra-marathoners with the assumption that older runners would slow down more than younger runners.

Methods

The annual ten fastest finishers (i.e. elite and age group runners) competing between 2000 and 2009 in the ‘100 km Lauf Biel’ were identified. Normalised average running speed (i.e. relative to segment 1 of the race corrected for gradient) was analysed as a proxy for pacing in elite and age group finishers. For each year, the ratio of the running speed from the final to the first segment for each age cohort was determined. These ratios were combined across years with the assumption that there were no ‘extreme’ wind events etc. which may have impacted the final relative to the first segment across years. The ratios between the age cohorts were compared using one-way ANOVA and Tukey’s post-hoc test. The ratios between elite and age group runners were investigated using one-way ANOVA with Dunnett’s multiple comparison post-hoc tests. The trend across age groups was investigated using simple regression analysis with age as the dependent variable.

Results

Normalised average running speed was different between age group 18–24 years and age groups 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59 and 65–69 years. Regression analysis showed no trend across age groups (r² = 0.003, p > 0.05).

Conclusion

To summarize, (i) athletes in age group 18–24 years were slower than athletes in most other age groups and (ii) there was no trend of slowing down for older athletes.

Age and ultra-marathon performance - 50 to 1,000 km distances from 1969 - 2012

We investigated age and performance in distance-limited ultra-marathons held from 50 km to 1,000 km. Age of peak running speed and running speed of the fastest competitors from 1969 to 2012 in 50 km, 100 km, 200 km and 1,000 km ultra-marathons were analyzed using analysis of variance and multi-level regression analyses. The ages of the ten fastest women ever were 40 ± 4 yrs (50 km), 34 ± 7 yrs (100 km), 42 ± 6 yrs (200 km), and 41 ± 5 yrs (1,000 km). The ages were significantly different between 100 km and 200 km and between 100 km and 1,000 km. For men, the ages of the ten fastest ever were 34 ± 6 yrs (50 km), 32 ± 4 yrs (100 km), 44 ± 4 yrs (200 km), and 47 ± 9 yrs (1,000 km). The ages were significantly younger in 50 km compared to 100 km and 200 km and also significantly younger in 100 km compared to 200 km and 1,000 km. The age of the annual ten fastest women decreased in 50 km from 39 ± 8 yrs (1988) to 32 ± 4 yrs (2012) and in men from 35 ± 5 yrs (1977) to 33 ± 5 yrs (2012). In 100 km events, the age of peak running speed of the annual ten fastest women and men remained stable at 34.9 ± 3.2 and 34.5 ± 2.5 yrs, respectively. Peak running speed of top ten runners increased in 50 km and 100 km in women (10.6 ± 1.0 to 15.3 ± 0.7 km/h and 7.3 ± 1.5 to 13.0 ± 0.2 km/h, respectively) and men (14.3 ± 1.2 to 17.5 ± 0.6 km/h and 10.2 ± 1.2 to 15.1 ± 0.2 km/h, respectively). In 200 km and 1,000 km, running speed remained unchanged. In summary, the best male 1,000 km ultra-marathoners were ~15 yrs older than the best male 100 km ultra-marathoners and the best female 1,000 km ultra-marathoners were ~7 yrs older than the best female 100 km ultra-marathoners. The age of the fastest 50 km ultra-marathoners decreased across years whereas it remained unchanged in 100 km ultra-marathoners. These findings may help athletes and coaches to plan an ultra-marathoner's career. Future studies are needed on the mechanisms by which the fastest runners in the long ultra-marathons tend to be older than those in shorter ultra-marathons.

What is the age for the fastest ultra-marathon performance in time-limited races from 6 h to 10 days?

Recent findings suggested that the age of peak ultra-marathon performance seemed to increase with increasing race distance. The present study investigated the age of peak ultra-marathon performance for runners competing in time-limited ultra-marathons held from 6 to 240 h (i.e. 10 days) during 1975-2013. Age and running performance in 20,238 (21%) female and 76,888 (79%) male finishes (6,863 women and 24,725 men, 22 and 78%, respectively) were analysed using mixed-effects regression analyses. The annual number of finishes increased for both women and men in all races. About one half of the finishers completed at least one race and the other half completed more than one race. Most of the finishes were achieved in the fourth decade of life. The age of the best ultra-marathon performance increased with increasing race duration, also when only one or at least five successful finishes were considered. The lowest age of peak ultra-marathon performance was in 6 h (33.7 years, 95% CI 32.5-34.9 years) and the highest in 48 h (46.8 years, 95% CI 46.1-47.5). With increasing number of finishes, the athletes improved performance. Across years, performance decreased, the age of peak performance increased, and the age of peak ultra-marathon performance increased with increasing number of finishes. In summary, the age of peak ultra-marathon performance increased and performance decreased in time-limited ultra-marathons. The age of peak ultra-marathon performance increased with increasing race duration and with increasing number of finishes. These athletes improved race performance with increasing number of finishes.

Will the age of peak ultra-marathon performance increase with increasing race duration?

Background

Recent studies found that the athlete’s age of the best ultra-marathon performance was higher than the athlete’s age of the best marathon performance and it seemed that the athlete’s age of peak ultra-marathon performance increased in distance-limited races with rising distance.

Methods

We investigated the athlete’s age of peak ultra-marathon performance in the fastest finishers in time-limited ultra-marathons from 6 hrs to 10 d. Running performance and athlete’s age of the fastest women and men competing in 6 hrs, 12 hrs, 24 hrs, 48 hrs, 72 hrs, 144 hrs (6 d) and 240 hrs (10 d) were analysed for races held between 1975 and 2012 using analysis of variance and multi-level regression analysis.

Results

The athlete’s ages of the ten fastest women ever in 6 hrs, 12 hrs, 24 hrs, 48 hrs, 72 hrs, 6 d and 10 d were 41 ± 9, 41 ± 6, 42 ± 5, 46 ± 5, 44 ± 6, 42 ± 4, and 37 ± 4 yrs, respectively. The athlete’s age of the ten fastest women was different between 48 hrs and 10 d. For men, the athlete’s ages were 35 ± 6, 37 ± 9, 39 ± 8, 44 ± 7, 48 ± 3, 48 ± 8 and 48 ± 6 yrs, respectively. The athlete’s age of the ten fastest men in 6 hrs and 12 hrs was lower than the athlete’s age of the ten fastest men in 72 hrs, 6 d and 10 d, respectively.

Conclusion

The athlete’s age of peak ultra-marathon performance did not increase with rising race duration in the best ultra-marathoners. For the fastest women ever in time-limited races, the athlete’s age was lowest in 10 d (~37 yrs) and highest in 48 hrs (~46 yrs). For men, the athlete’s age of the fastest ever in 6 hrs (~35 yrs) and 12 hrs (~37 yrs) was lower than the athlete’s age of the ten fastest in 72 hrs (~48 yrs), 6 d (~48 yrs) and 10 d (~48 yrs). The differences in the athlete’s age of peak performance between female and male ultra-marathoners for the different race durations need further investigations.

Will women outrun men in ultra-marathon road races from 50 km to 1,000 km?

It has been assumed that women would be able to outrun men in ultra-marathon running. The present study investigated the sex differences in running speed in ultra-marathons held worldwide from 50 km to 1,000 km. Changes in running speeds and the sex differences in running speeds in the annual fastest finishers in 50 km, 100 km, 200 km and 1,000 km events held worldwide from 1969–2012 were analysed using linear, non-linear and multi-level regression analyses. For the annual fastest and the annual ten fastest finishers, running speeds increased non-linearly in 50 km and 100 km, but not in 200 km and 1,000 km where running speeds remained unchanged for the annual fastest. The sex differences decreased non-linearly in 50 km and 100 km, but not in 200 and 1,000 km where the sex difference remained unchanged for the annual fastest. For the fastest women and men ever, the sex difference in running speed was lowest in 100 km (5.0%) and highest in 50 km (15.4%). For the ten fastest women and men ever, the sex difference was lowest in 100 km (10.0 ± 3.0%) and highest in 200 km (27.3 ± 5.7%). For both the fastest (r² = 0.003, p = 0.82) and the ten fastest finishers ever (r² = 0.34, p = 0.41) in 50 km, 100 km, 200 km and 1,000 km, we found no correlation between sex difference in performance and running speed. To summarize, the sex differences in running speeds decreased non-linearly in 50 km and 100 km but remained unchanged in 200 km and 1,000 km, and the sex differences in running speeds showed no change with increasing length of the race distance. These findings suggest that it is very unlikely that women will ever outrun men in ultra-marathons held from 50 km to 100 km.

Health and exercise-related medical issues among 1,212 ultramarathon runners: baseline findings from the Ultrarunners Longitudinal TRAcking (ULTRA) Study

Regular exercise is associated with substantial health benefits; however, little is known about the health impact of extreme levels of exercise. This study examined the prevalence of chronic diseases, health-care utilization, and risk factors for exercise-related injuries among ultramarathon runners. Retrospective, self-reported enrollment data from an ongoing longitudinal observational study of 1,212 active ultramarathon runners were analyzed. The most prevalent chronic medical conditions were allergies/hay fever (25.1%) and exercise-induced asthma (13.0%), but there was a low prevalence of serious medical issues including cancers (4.5%), coronary artery disease (0.7%), seizure disorders (0.7%), diabetes (0.7%), and human immunodeficiency virus (HIV) infection (0.2%). In the year preceding enrollment, most (64.6%) reported an exercise-related injury that resulted in lost training days (median of 14 days), but little nonattendance of work or school due to illness, injury, or exercise-related medical conditions (medians of 0 days for each). The knee was the most common area of exercise-related injury. Prior year incidence of stress fractures was 5.5% with most (44.5%) involving the foot. Ultramarathon runners who sustained exercise-related injuries were younger (p<0.001) and less experienced (p<0.01) than those without injury. Stress fractures were more common (p<0.01) among women than men. We conclude that, compared with the general population, ultramarathon runners appear healthier and report fewer missed work or school days due to illness or injury. Ultramarathon runners have a higher prevalence of asthma and allergies than the general population, and the prevalence of serious medical issues was nontrivial and should be recognized by those providing medical care to these individuals. Ultramarathon runners, compared with shorter distance runners, have a similar annual incidence of exercise-related injuries but higher proportion of stress fractures involving the foot, and it is the younger and less experienced ultramarathoners who appear most at risk for injury.